Learn More
Medchemexpress LLC 1-benzyl-3-cyclohexyl-1-(piperidin-4-ylmethyl)urea hydrochloride | 2070014-88-7 | 99.6% | 365.94 g/mol | C20H32ClN3O | 100 MG

Supplier: Medchemexpress LLC HY100347100MG
SRI-011381 hydrochloride is an orally active small-molecule agonist of the transforming growth factor-β (TGF-β)/Smad signaling pathway. Supplied as a purified hydrochloride salt for research use, it has been reported to exhibit neuroprotective effects and to modulate TGF-β-dependent cellular responses in vitro and in vivo. The material is provided as a solid with high analytical purity suitable for preclinical experiments.
- Orally active TGF-β/Smad signaling agonist.
- Exhibits reported neuroprotective effects in preclinical studies.
- Supplied as a hydrochloride solid suitable for formulation and dosing.
- High purity for research applications.
- Molecular weight 365.94 g/mol; CAS 2070014-88-7.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.